ScinoPharm Taiwan, Ltd.

TWSE:1789 Rapporto sulle azioni

Cap. di mercato: NT$18.7b

ScinoPharm Taiwan Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Susan Lu

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO3.8yrs
Proprietà del CEOn/a
Durata media del management4.3yrs
Durata media del Consiglio di amministrazione6.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

ScinoPharm Taiwan's (TWSE:1789) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 17
ScinoPharm Taiwan's (TWSE:1789) Shareholders Will Receive A Smaller Dividend Than Last Year

Investors In ScinoPharm Taiwan, Ltd. (TPE:1789) Should Consider This, First

Apr 04
Investors In ScinoPharm Taiwan, Ltd. (TPE:1789) Should Consider This, First

A Look At The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Mar 14
A Look At The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Weak Financial Prospects Seem To Be Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789) Stock

Feb 21
Weak Financial Prospects Seem To Be Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789) Stock

ScinoPharm Taiwan's (TPE:1789) Shareholders Are Down 45% On Their Shares

Jan 25
ScinoPharm Taiwan's (TPE:1789) Shareholders Are Down 45% On Their Shares

We Think ScinoPharm Taiwan (TPE:1789) Can Manage Its Debt With Ease

Jan 04
We Think ScinoPharm Taiwan (TPE:1789) Can Manage Its Debt With Ease

Estimating The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Dec 14
Estimating The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Are Poor Financial Prospects Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789 Stock?

Nov 23
Are Poor Financial Prospects Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789 Stock?

AMMINISTRATORE DELEGATO

Susan Lu

3.8yrs

Mandato

Ms. Li-An Lu, also known as Susan, is Director of SciAnda (Changshu) Pharmaceutical, Ltd. from June 14, 2024. She serves as President and Chief Executive Officer at ScinoPharm Taiwan, Ltd.since 2021. She...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Chih-Hsien Lo
Chairman & General Chief Strategy Officer14.3yrsNessun datoNessun dato
Li-An Lu
President & CEO3.8yrsNessun datoNessun dato
Chih-Hui Lin
Acting Financial Off.14.4yrsNessun datoNessun dato
Ling-Hsiao Lien
Vice-President of Marketing4.3yrsNessun datoNessun dato
Li-Chiao Chang
VP of R&D Division and Chief Scientific Officerno dataNessun dato0%
NT$ 0
Jason Chen
Director of Human Resources & Admin3.4yrsNessun datoNessun dato
Shun Yang Lin
Director of Corporate Developmentno dataNessun datoNessun dato

4.3yrs

Durata media

Gestione esperta: Il team dirigenziale di 1789 è considerato esperto (durata media dell'incarico 4.3 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Chih-Hsien Lo
Chairman & General Chief Strategy Officer14.3yrsNessun datoNessun dato
Po-Ming Hou
Representative Director8yrsNessun datoNessun dato
Fu-Jung Lai
Representative Director6.1yrsNessun datoNessun dato
Shiow-Ling Kao
Representative Director14.3yrsNessun datoNessun dato
Chiou-Ru Shih
Representative Director14.3yrsNessun datoNessun dato
Tsung-Ping Wu
Representative Director9.4yrsNessun datoNessun dato
Jia-Horng Guo
Representative Director7.3yrsNessun datoNessun dato
Li-Tzong Chen
Independent Director6.4yrsNessun datoNessun dato
Ming-Chuan Hsieh
Representative Director6.4yrsNessun datoNessun dato
Ya-Po Yang
Representative Director6.4yrsNessun datoNessun dato
Wen-Chang Chang
Independent Director6.4yrsNessun datoNessun dato
Lewis Lee
Independent Director3.8yrsNessun datoNessun dato

6.8yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1789 sono considerati esperti (durata media dell'incarico 6.8 anni).